PDUFA date of June 13th 2025 by which FDA will decide upon whether or not UGN-102 should be approved for patients with ...

ODDITY had $257 million in cash, and an undrawn $200 million credit lineCapital raise gives ODDITY additional firepower to play offense and pursue future opportunities ...